Now decides next: Generating a new future

The State of Generative AI in the Enterprise series reveals that no matter how quickly GenAI advances, organisational change only happens so fast. ROI with AI is encouraging, regulation and risk loom large, and agentic AI is on the rise—but businesses are setting their own pace on the path to value.

Read the full report to see how far organisations came in 2024 and where things are headed in 2025.

Key takeaways

After surveying 2,800 leaders across the globe, Deloitte found:

• GenAI access remains limited to under 40% of the workforce. This suggests many companies are yet to integrate GenAI into their standard business workflows.
• Over two-thirds of respondents say that 30% or fewer of their current experiments will be fully scaled in the next three to six months. This suggests companies are cautiously evaluating GenAI's capabilities and optimal applications.
• "Improved efficiency and productivity" remain the top benefit sought from GenAI, with 40% of organisations achieving expected benefits to a large or very large extent.
• The most advanced (scaled) GenAI initiatives are in IT function (28%). Furthermore, nearly 74% of respondents report their most advanced initiatives are meeting (43%) or exceeding (31%) ROI Expectations.
• Regulatory compliance (38%) seems to become the top barrier to GenAI development and deployment, while Mistakes/Errors with real-world consequences (35%) pose the greatest potential to slow its marketplace adoption.
• Agentic AI (52%) and Multi-Agent Systems (45%) are key focus areas for future GenAI, with 26% of respondents extensively exploring autonomous agent development to a large or very large extent.

Read the full report